SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001683168-19-002573
Filing Date
2019-08-13
Accepted
2019-08-13 16:44:55
Documents
60
Period of Report
2019-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q sonoma_10q-063019.htm 10-Q 379162
2 CERTIFICATION OF CHIEF EXECUTIVE OFFICER sonoma_ex3101.htm EX-31.1 8479
3 CERTIFICATION OF CHIEF FINANCIAL OFFICER sonoma_ex3102.htm EX-31.2 8492
4 CERTIFICATION sonoma_ex3201.htm EX-32.1 3780
  Complete submission text file 0001683168-19-002573.txt   2367374

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE FILE snoa-20190630.xml EX-101.INS 344420
6 XBRL SCHEMA FILE snoa-20190630.xsd EX-101.SCH 26519
7 XBRL CALCULATION FILE snoa-20190630_cal.xml EX-101.CAL 52844
8 XBRL DEFINITION FILE snoa-20190630_def.xml EX-101.DEF 83743
9 XBRL LABEL FILE snoa-20190630_lab.xml EX-101.LAB 220665
10 XBRL PRESENTATION FILE snoa-20190630_pre.xml EX-101.PRE 187749
Mailing Address 1129 N. MCDOWELL BLVD. PETALUMA CA 94954
Business Address 1129 N. MCDOWELL BLVD. PETALUMA CA 94954 707-283-0550
Sonoma Pharmaceuticals, Inc. (Filer) CIK: 0001367083 (see all company filings)

IRS No.: 680423298 | State of Incorp.: DE | Fiscal Year End: 0331
Type: 10-Q | Act: 34 | File No.: 001-33216 | Film No.: 191021298
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1